Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Federal Trade Commission
McKesson
US Army
Cerilliant
QuintilesIMS
Cipla
Citi
Cantor Fitzgerald

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086101

« Back to Dashboard

NDA 086101 describes SECONAL SODIUM, which is a drug marketed by Valeant Pharms North and Lilly and is included in three NDAs. It is available from one supplier. Additional details are available on the SECONAL SODIUM profile page.

The generic ingredient in SECONAL SODIUM is secobarbital sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the secobarbital sodium profile page.
Summary for 086101
Tradename:SECONAL SODIUM
Applicant:Valeant Pharms North
Ingredient:secobarbital sodium
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 086101
Suppliers and Packaging for NDA: 086101
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SECONAL SODIUM secobarbital sodium CAPSULE;ORAL 086101 ANDA Valeant Pharmaceuticals North America LLC 0187-4220 0187-4220-10 100 CAPSULE in 1 BOTTLE (0187-4220-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Oct 3, 1983TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Oct 3, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Citi
Merck
Fuji
Fish and Richardson
Chinese Patent Office
Dow
Accenture
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot